OSI-930
98%
- Product Code: 124780
CAS:
728033-96-3
| Molecular Weight: | 443.44 g./mol | Molecular Formula: | C₂₂H₁₆F₃N₃O₂S |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD11100358 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20℃ |
Product Description:
OSI-930 is primarily utilized in the field of oncology as a targeted therapy agent. It functions as an inhibitor of multiple receptor tyrosine kinases, including KIT, VEGFR, and PDGFR, which are often implicated in the growth and proliferation of certain cancers. By blocking these signaling pathways, OSI-930 helps to inhibit tumor angiogenesis and cancer cell survival. It has been investigated in preclinical and clinical studies for its potential in treating solid tumors, such as gastrointestinal stromal tumors (GIST) and renal cell carcinoma. Additionally, its ability to target multiple kinases makes it a candidate for combination therapies, enhancing the efficacy of other anticancer treatments. Research continues to explore its full therapeutic potential and optimal use in cancer treatment regimens.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.001 | 10-20 days | ฿756.00 |
+
-
|
| 0.005 | 10-20 days | ฿2,394.00 |
+
-
|
| 0.025 | 10-20 days | ฿5,427.00 |
+
-
|
OSI-930
OSI-930 is primarily utilized in the field of oncology as a targeted therapy agent. It functions as an inhibitor of multiple receptor tyrosine kinases, including KIT, VEGFR, and PDGFR, which are often implicated in the growth and proliferation of certain cancers. By blocking these signaling pathways, OSI-930 helps to inhibit tumor angiogenesis and cancer cell survival. It has been investigated in preclinical and clinical studies for its potential in treating solid tumors, such as gastrointestinal stromal tumors (GIST) and renal cell carcinoma. Additionally, its ability to target multiple kinases makes it a candidate for combination therapies, enhancing the efficacy of other anticancer treatments. Research continues to explore its full therapeutic potential and optimal use in cancer treatment regimens.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :